Detalhe da pesquisa
1.
Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial.
Respir Res
; 21(1): 177, 2020 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32646424
2.
Effects of tiotropium + olodaterol versus tiotropium or placebo by COPD disease severity and previous treatment history in the OTEMTO® studies.
Respir Res
; 17(1): 73, 2016 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-27316465
3.
Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4).
Eur Respir J
; 45(4): 969-79, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25573406
4.
The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary disease.
Pulm Pharmacol Ther
; 32: 53-9, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25956072
5.
Author correction. Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4).
Eur Respir J
; 45(6): 1763, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26028626
6.
Effects of baseline symptom burden on treatment response in COPD.
Int J Chron Obstruct Pulmon Dis
; 14: 181-194, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30655665
7.
ß-Blockers in COPD: A Cohort Study From the TONADO Research Program.
Chest
; 153(6): 1315-1325, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29355547
8.
Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial.
Lancet Respir Med
; 6(5): 337-344, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29605624
9.
Long-term safety and efficacy of combined tiotropium and olodaterol in Japanese patients with chronic obstructive pulmonary disease.
Respir Investig
; 55(2): 121-129, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28274527
10.
Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies.
NPJ Prim Care Respir Med
; 27(1): 7, 2017 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28154373
11.
Study Design of VESUTO®: Efficacy of Tiotropium/Olodaterol on Lung Hyperinflation, Exercise Capacity, and Physical Activity in Japanese Patients with Chronic Obstructive Pulmonary Disease.
Adv Ther
; 34(7): 1622-1635, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28537001
12.
Efficacy and safety of tiotropium + olodaterol maintenance treatment in patients with COPD in the TONADO® and OTEMTO® studies: a subgroup analysis by age.
Int J Chron Obstruct Pulmon Dis
; 11: 2701-2710, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27843306
13.
The lung function profile of once-daily tiotropium and olodaterol via Respimat(®) is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler(®) (ENERGITO(®) study).
Int J Chron Obstruct Pulmon Dis
; 11: 193-205, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26893551
14.
The efficacy and safety of combined tiotropium and olodaterol via the Respimat(®) inhaler in patients with COPD: results from the Japanese sub-population of the Tonado(®) studies.
Int J Chron Obstruct Pulmon Dis
; 11: 2017-27, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27621608
15.
Effect of cetirizine dihydrochloride on the airway response to hypertonic saline aerosol in patients with chronic obstructive pulmonary disease (COPD).
Respir Med
; 99(10): 1241-8, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16140224
16.
Efficacy of Tiotropium + Olodaterol in Patients with Chronic Obstructive Pulmonary Disease by Initial Disease Severity and Treatment Intensity: A Post Hoc Analysis.
Adv Ther
; 32(6): 523-36, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26112656
17.
Tiotropium + olodaterol shows clinically meaningful improvements in quality of life.
Respir Med
; 109(10): 1312-9, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26320402
18.
Effect of azelastine, montelukast, and their combination on allergen-induced bronchoconstriction in asthma.
Pulm Pharmacol Ther
; 21(1): 61-6, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-17239638